MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY

Japanese Journal of Cancer Research

Volumn 79, Issue 3, 1988, Pages 285-296

  Tsuruo, Takashi ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; VINBLASTINE;

CANCER CHEMOTHERAPY; DRUG RESISTANCE; HUMAN; NONHUMAN; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE; HUMAN; NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0023888724     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1988.tb01588.x     Document Type: Review

References (84)

1. Altered plasma membrane glyco‐conjugates of Chinese hamster cells with acquired resistance to actinomycin D, daunorubicin and vincristine
2. Genetic basis of drug resistance in mammalian cells
3. Symposium on cellular resistance to anticancer drugs
4. Development of multidrug resistance in rodent cell lines
5. Correlation of double‐minute chromosomes with unstable multidrug cross‐resistance in uptake mutants of neuroblastoma cells
6. Drug resistance in Chinese hamster lung and mouse tumor cells
7. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones
8. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response
9. Pleiotropic phenotype of colchicine‐resistant CHO cells: cross‐resistance and collateral sensitivity
10. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross‐resistance, radioautographic, and cytogenetic studies
11. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo
12. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells
13. In vivo characteristics of resistance and cross‐resistance of an adriamycin‐resistant subline of P388 leukemia
14. Reduced permeability in CHO cells as a mechanism of resistance to colchicine
15. Mechanism of cross‐resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells
16. Resistance and cross‐resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D
17. Establishment and properties of vincristine‐resistant human myelogenous leukemia K562
18. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia
19. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
20. Daunorubicin‐resistant Chinese hamster ovary cells expressing multidrug resistance and cell‐surface P‐glycoprotein
21. Multidrug resistance phenotype in Chinese hamster ovary cells
22. Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine
23. Altered surface membrane glycoproteins in vinca alkaloid‐resistant human leukemic lymphoblasts
24. Isolation and characterization of an anthracycline‐resistant human leukemic cell line
25. Amplification of P‐glycoprotein genes in multidrugresistant mammalian cell lines
26. Increased synthesis of a low molecular weight protein in vincristine‐resistant cells
27. Gene amplification‐associated cytogenetic aberrations and protein changes in vincristine‐resistant Chinese hamster, mouse, and human cells
28. Pleiotropic drug resistance and gene amplification in a SEWA mouse tumor cell line: complex relations revealed by drug uptake data, and lipid and protein analysis
29. High calcium content of pleiotropic drug‐resistant P388 and K562 leukemia and Chinese hamster ovary cells
30. Calcium, calmodulin, and protein content of adriamycin‐resistant and ‐sensitive murine leukemic cells
31. Increased accumulation of vincristine and adriamycin in drug‐resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
32. Enhancement of vincristine‐ and adriamycin‐induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin
33. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics
34. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug
35. Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors
36. Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers
37. Reversal of multidrug resistance by calcium channel blockers and other agents
38. Protective role of the glutathione redox cycle against adriamycin‐mediated toxicitiy in isolated hepatocytes
39. Mixed‐function oxidase enzymes in adriamycin‐sensitive and ‐resistant sublines of P388 leukemia
40. Mutants of Chinese hamster ovary (CHO) cells with altered colcemidbinding affinity
41. CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β‐tubulin
42. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered β‐tubulins
43. Co‐amplification of double minute chromosomes, multiple drug resistance and cell surface P‐glycoprotein in DNA‐mediated transformants of mouse cells
44. Amplification and expression of genes associated with multidrug resistance in mammalian cells
45. Overexpression and amplification of five genes in a multidrug‐resistant Chinese hamster ovary cell line
46. Differential amplification and disproportionate expression of five genes in three multidrug‐resistant Chinese hamster cell lines
47. Detection and mapping of homologous, repeated and amplified DNA sequences by DNA renaturation in agarose gels
48. Amplification of specific DNA sequences correlates with multi‐drug resistance in Chinese hamster cells
49. Isolation and characterization of DNA sequences amplified in multidrug‐resistant hamster cells
50. Isolation of human mdr DNA sequences amplified in multidrug‐resistant KB carcinoma cells
51. DNA‐mediated transfer and cloning of a human multidrug‐resistant gene of adriamycinresistant myelogenous leukemia K562
52. The mdr1 gene, responsible for multidrug‐resistance, codes for P‐glycoprotein
53. Isolation and expression of a complementary DNA that confers multidrug resistance
54. Multidrug resistance of DNA‐mediated transformants is linked to transfer of the human mdr1 gene
55. Expression of a full‐length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin, and vinblastine
56. Internal duplication and homology with bacterial transport proteins in the mdr1 (P‐glycoprotein) gene from multidrug‐resistant human cells
57. Homology between P‐glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
58. Membrane vesicles from multidrug‐resistant human cancer cells contain a specific 150‐ to 170‐kDa protein detected by photoaffinity labeling
59. Certain calcium channel blockers bind specifically to multidrug‐resistant human KB carcinoma membrane vesicles and inhibit drug binding to P‐glycoprotein
60. Purification of the P‐glycoprotein associated with multidrug resistance. P‐Glycoprotein is an ATPase
61. The human multidrug resistance (mdr1) gene
62. Functional role for the 170‐ to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies
63. Growth inhibition of multidrug‐resistant cells by monoclonal antibodies against P‐glycoprotein
64. Monoclonal antibodies to glycoproteins of vinca alkaloid‐resistant human leukemic cells
65. Detection of P‐glycoprotein in multidrug‐resistant cell lines by monoclonal antibodies
66. Expression of a multidrug‐resistance gene in human tumors and tissues
67. Expression of the multidrug‐resistant gene in hepatocarcinogenesis and regenerating rat liver
68. The location of the multidrug resistance gene‐product P‐glycoprotein in normal tissues
69. r 170,000 to 180,000 glycoprotein specific to multidrug‐resistant tumor cells: effect of verapamil, trifluoperazine, and phorbol esters
70. Activation of protein kinase C (PKC) increases vincristine (VC) efflux and resistance in drug‐sensitive MCF‐7 cells
71. Dimethylsulfoxide, retinoic acid and 12‐O‐tetradecanoylphorbol‐13‐acetate induce a selective decrease in the phosphorylation of P150, a surface membrane phosphoprotein of HL60 cells resistant to adriamycin
72. Human multidrug‐resistant cell lines: increased mdrl expression can precede gene amplification
73. Detection of P‐glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance
74. Detection of multidrug resistance markers, P‐glycoprotein and mdr1 mRNA, in human leukemia cells
75. A monoclonal antibody‐Pseudomonas toxin conjugate that specifically kills multidrug‐resistant cells
76. Antitumor effect of CPT‐11, a new derivative of camptothecin, against pleiotropic drug‐resistant tumors in vitro and in vivo
77. Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazem
78. Verapamil reversal of clinical doxorubicin resistance in human cancer: a Wilshire Oncology Medical Group pilot phase I‐II study
79. The effect of verapamil on the pharmacokinetics of adriamycin
80. Overexpression of a novel anionic glutathione transferase in multidrug‐resistant human breast cancer cells
81. The multidrug resistant phenotype and its relationship to glutathione
82. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug‐resistant and ‐sensitive human ovarian carcinoma cell lines by buthionine sulfoximine‐mediated glutathione depletion
83. Comparison of glutathione S‐transferase activity between drug‐resistant and ‐sensitive human tumor cells: is glutathione S‐transferase associated with drug‐resistance